Advances in Molecular Subtyping, Characteristics and Therapeutic Strategies of Small Cell Lung Cancer.
WU Yang, Z Jing, W Mengzhao - Chinese Journal of Lung …, 2023 - search.ebscohost.com
Small cell lung cancer (SCLC) is a malignant tumor with remarkable proliferative and
invasive ability, which has very poor clinical prognosis due to lack of effective treatments. In …
invasive ability, which has very poor clinical prognosis due to lack of effective treatments. In …
Genome-scale CRISPR-Cas9 screen identifies PAICS as a therapeutic target for EGFR wild-type NSCLC
H Shen, LI Yufeng, J Wang, J Mao, H Zheng, L Zhu… - 2023 - researchsquare.com
EGFR-targeted therapies for NSCLC have made promising progress, whereas one-third of
NSCLC patients do not benefit from them due to lack of EGFR mutations. Therefore …
NSCLC patients do not benefit from them due to lack of EGFR mutations. Therefore …
Genome-Scale CRISPR-Cas9 Screen Identifies PAICS as a Therapeutic Target for EGFR Wild-Type NSCLC
Y Li, J Wang, J Mao, H Zheng, L Zhu, Z Hu, T Mao… - papers.ssrn.com
EGFR-targeted therapies for NSCLC have made promising progress, whereas one-third of
NSCLC patients do not benefit from them due to lack of EGFR mutations. Therefore …
NSCLC patients do not benefit from them due to lack of EGFR mutations. Therefore …